Vækstfonden has invested $19.27m in Egalet, a pharmaceutical company that specialises in oral controlled released products. The investment will be used to expand and optimise its proprietary product portfolio.
Nutrisens management team, led by CEO Georges Devesa, retains a significant stake in the company
Intention to list comes four years after the GP acquired the company via its fourth fund
Online optician has previously received VC funding from investors including Grazia Equity and Goldman Sachs
Platform will enable smaller investors to put their secondaries stakes up for sale